Francesca Petralia

Biochemistry, Genetics and Molecular Biology · Life Sciences

33h-index9.8kcitations147works5.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(44), Microscopic Colitis(24), Ferroptosis and cancer prognosis(23), Cancer Genomics and Diagnostics(20), Bioinformatics and Genomic Networks(18)

Publications145 total

COMBINATION THERAPY OF RESILIENCE INTERVENTION WITH BIOLOGICS IN CROHN’S DISEASE (CATHARSIS) IS MET WITH EARLY ACCEPTABILITY AND HIGH EXPECTANCY
Inflammatory Bowel Diseases·2026Open Access
COMBINATION THERAPY OF RESILIENCE INTERVENTION WITH BIOLOGICS IN CROHN'S DISEASE (CATHARSIS) IS MET WITH EARLY ACCEPTABILITY AND HIGH EXPECTANCY
Gastroenterology·2026
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers
UNC Libraries·2025Open Access
Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (CATHARSIS): Study protocol for a randomized controlled trial
Contemporary Clinical Trials·2025· 1 cited
Disease duration impacts intestinal gene expression profiles in Crohn’s disease but not in ulcerative colitis
Journal of Crohn s and Colitis·2025
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Cancer Cell·2025· 2 citedOpen Access
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers
Cell Reports Medicine·2025· 1 citedOpen Access
418: CHANGES IN CELLULAR GLYCOSYLATION ARE ASSOCIATED WITH AN INCREASED INTESTINAL PERMEABILITY AND PRECEDE BY UP TO 6 YEARS THE DEVELOPMENT OF CRONHS DISEASE.
Gastroenterology·2025
1303: AN INTEGRATIVE BLOOD-BASED RISK SCORE PREDICTS DEVELOPMENT OF CROHN’S DISEASE
Gastroenterology·2025
743: ANTI-GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR AUTOANTIBODIES DEFINE A DISTINCT SUB-PHENOTYPE OF CROHN’S DISEASE
Gastroenterology·2025
408: BROAD LANDSCAPE OF ANTIMICROBIAL AND AUTOANTIBODY SIGNATURES REVEALS SELECTIVE REACTIVITY IN THE PRE-CLINICAL PHASE OF INFLAMMATORY BOWEL DISEASE
Gastroenterology·2025
Tu1177: HIV-1 VIREMIA IS ASSOCIATED WITH LOSS OF INTESTINAL GERMINAL CENTER B CELLS
Gastroenterology·2025
Su1968: SINGLE CELL ANALYSIS OF LESIONAL TISSUES IN ACUTE SEVERE ULCERATIVE COLITIS IDENTIFIES ENRICHMENT OF TH17-POLARIZED CELLS
Gastroenterology·2025
Abstract 5019: Genomic landscape, tumor heterogeneity and immune-related post-translational regulation in cutaneous melanoma
Cancer Research·2025
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets
Cell Genomics·2025· 3 citedOpen Access
Epstein-Barr Virus Exposure Precedes Crohn's Disease Development
Gastroenterology·2025· 13 cited
P0126 Single-cell analysis reveals enrichment of mucosal Th17-polarized T cells in Acute Severe Ulcerative Colitis
Journal of Crohn s and Colitis·2025· 1 citedOpen Access
OP01 Systemic antibody responses predict the onset of Inflammatory Bowel Disease up to 10 years before diagnosis
Journal of Crohn s and Colitis·2025· 1 cited
P0558 An Integrative Blood-Based Risk Score Predicts Development of Crohn's Disease
Journal of Crohn s and Colitis·2025Open Access
Combination Therapy of Resilience Intervention with Biologics in Crohn's Disease (Catharsis): Study Protocol for a Randomized Controlled Trial
SSRN Electronic Journal·2025Open Access
page 1 of 8Next →

Frequent Co-authors

Pei Wang(26), David Fenyö(18), Boris Reva(17), Anna Calinawan(17), Jean‐Frédéric Colombel(17), Amanda G. Paulovich(16), Weiping Ma(16), Henry Rodriguez(15), Li Ding(15), Alexey I. Nesvizhskii(15), Mehdi Mesri(14), Antonio Colaprico(14), Felipe da Veiga Leprevost(14), Ana I. Robles(14), D.R. Mani(13), Yize Li(13), Marcin Cieślik(13), Chet Birger(13), Bing Zhang(12), Saravana M. Dhanasekaran(12)